search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    RedHill Biopharma Ltd.

    (NASDAQ:RDHL)

    $0.95

    $0.11

    12.86%

    RedHill Biopharma Ltd. Chart

    RDHL Stock Price Today

    RedHill Biopharma Ltd. (RDHL) stock rallied over 12.86% intraday to trade at $0.95 a share on NASDAQ. The stock opened with a gain of 15.85% at $0.85 and touched an intraday high of $0.87, rising 9.20% against the last close of $0.87. The stock went to a low of $0.82 during the session.

    Stock Snapshot

    $0.87

    Prev. Close

    52.23 Million

    Market Cap

    $0.82

    Day Low

    $0.85

    Open

    52.52 Million

    Number of Shares

    $0.87

    Day High

    -

    P/E ratio

    -1.90

    EPS (TTM)

    0.72

    Cash Flow per Share

    3.63

    Free Float in %

    0.25

    Book Value

    2,458,455

    Volume

    RedHill Biopharma Ltd. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$0.85$0.87$0.82$0.8421,062,500
    2022-06-30$0.82$0.88$0.791$0.871,365,700
    2022-06-29$0.9$0.91$0.83$0.852,407,000
    2022-06-28$1.02$1.02$0.87$0.8826,299,400
    2022-06-27$0.855$1.03$0.83$1.0211,862,500
    2022-06-24$0.86$0.876$0.762$0.8217,107,900
    2022-06-23$1.02$1.02$0.72$0.76855,729,900
    2022-06-22$0.72$0.82$0.693$0.7673,822,500
    2022-06-21$0.691$0.719$0.655$0.6765,129,100
    2022-06-17$0.64$0.77$0.636$0.6361,809,300

    Contact Details

    21 Ha’arba’a Street
    Tel Aviv 6473921
    Israel

    Webiste:RDHL

    972 3 541 3131

    Company Information

    Employees-

    Beta1.95

    Sales or Revenue85.76 Million

    5Y Sales Change285.30%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.

    Frequently Asked Questions

    icon

    What is the current RedHill Biopharma Ltd. (RDHL) stock price?

    RedHill Biopharma Ltd. (NASDAQ: RDHL) stock price is $0.95 as of the last check on Friday, July 1. During the trading session, RDHL stock reached the peak price of $0.87 while $0.82 was the lowest point it dropped to.

    icon

    RDHL's industry and sector of operation?

    The NASDAQ listed RDHL is part of Pharmaceuticals industry that operates in the broader Health Care sector. RedHill Biopharma Ltd. , a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.

    icon

    Who are the executives of RDHL?

    Mr. Dror Ben-Asher
    Co-Founder, Chairman & CEO
    Mr. Micha Ben-Chorin
    Chief Financial Officer
    Mr. Gilead Raday MPhil, MSc
    Chief Operating Officer
    Mr. Adi Frish
    Chief Corp. & Bus. Devel. Officer

    icon

    What is the RDHL stock price today?

    RDHL stock traded closed the last session at $0.842, which is $0.11 or 12.86% lower than its previous close of $0.87. RDHL's current trading price is 53.19% lower than its 52-week high of $11.18 where as its distance from 52-week low of 0.62% is -91.50%.

    icon

    How many employees does RDHL have?

    Number of RDHL employees currently stands at -. RDHL operates from 21 Ha’arba’a Street, Tel Aviv 6473921, Israel.

    icon

    Link for RDHL official website?

    Official Webiste of $RDHL is: https://www.redhillbio.com

    icon

    How do I contact RDHL?

    RDHL could be contacted at RDHL operates from 21 Ha’arba’a Street, Tel Aviv 6473921, Israel, or at phone #972 3 541 3131 and can also be accessed through its website.

    icon

    How many shares of RDHL are traded daily?

    RDHL stock volume for the day was 2,458,455 shares while in the previous session number of RDHL shares traded was 1,062,500 . The average number of RDHL shares traded daily for last 3 months was 2.08 Million.

    icon

    How much did RDHL change today?

    The percentage change in RDHL stock occurred in the recent session was 12.86% while the dollar amount for the price change in RDHL stock was $0.11.

    icon

    What price range RDHL stock been trading in?

    In the recent session, the day high for RDHL stock was $0.87 while the low for RDHL stock touched on the day was $0.82.

    icon

    What is the market cap of RDHL currently?

    The market value of RDHL currently stands at 52.23 Million with its latest stock price at $0.95 and 52.52 Million of its shares outstanding.